Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Ray Sumita, holds the title of Chief Legal Compliance Officer at Cue Biopharma, Inc..
On 2026-08-13, the insider transacted 27,025 shares.The shares were transacted at a weighted average price of $9.83 per share, resulting in a total market-relevant value of $266K.
Ray Sumita (Chief Legal Compliance Officer) sold $266K of $CUE
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.